Physician profile
Catherine Jacobs
NPI 1174050637
$1,227.37
in general payments reported to CMS, 2019-2025
12 companies · $29.55 in 2025
The $29.55 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $161 · 2021: $183 · 2022: $247 · 2023: $42.80 · 2024: $564 · 2025: $29.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $455.48 | 2024 | |
| Smith+Nephew, INC. | $227.45 | 2020-2023 | Stravix Pl, Grafix Pl |
| Stryker Corporation | $131.54 | 2021-2022 | |
| Davol INC. | $97.57 | 2020 | |
| Nevro Corp. | $80.35 | 2021-2024 | Senza |
| Bioventus LLC | $56.02 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $42.94 | 2022 | |
| Orthofix Medical, INC. | $30.27 | 2022 | |
| Globus Medical, INC. | $29.55 | 2025 | Senza |
| Treace Medical Concepts, INC. | $29.30 | 2022 | |
| Kairos Surgical INC | $25.07 | 2024 | |
| Medtronic, INC. | $21.83 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.